Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Luis Miguel de Sande"'
Autor:
María Jesús Rubio, Aránzazu Manzano, Luis Miguel de Sande, Purificación Estévez-García, María del Mar Gordon, Diego Soto de Prado, Blanca Hernando Fernández de Aranguiz, Eva M. Guerra-Alia, Anna Carbó-Bagué, Ignacio Romero, Miguel Corbellas, Alba González-Haba, Carlos E. Robles-Barraza, Jerónimo Martínez-García, Antonio González-Martín
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background Trabectedin in combination with pegylated liposomal doxorubicin (PLD) is approved for the treatment of patients with platinum-sensitive relapsed ovarian cancer. Nevertheless, there is currently limited information regarding this t
Externí odkaz:
https://doaj.org/article/39144675c87243c3ade5b788dbad20d1
Autor:
Javier Martínez-Trufero, Luis Miguel De Sande-González, Pablo Luna, Javier Martin-Broto, Rosa Álvarez, Gloria Marquina, Roberto Diaz-Beveridge, Andrés Poveda, Juana María Cano, Josefina Cruz-Jurado, Antonio López Pousa, María Angeles Vaz Salgado, Claudia M. Valverde-Morales, Isabel Sevilla, Jerónimo Martínez-García, Jordi Rubio-Casadevall, Ana De Juan, Juan Antonio Carrasco, David S Moura, Ibon Gurruchaga-Sotes, Antonio Gutiérrez
Publikováno v:
Cancers, Vol 13, Iss 4, p 792 (2021)
The aim of this study was to identify an easily reliable prognostic score that selects the subset of advanced soft tissue sarcoma (ASTS) patients with a higher benefit with trabectedin in terms of time to progression and overall survival. A retrospec
Externí odkaz:
https://doaj.org/article/658332108b24418cb7586c389f4b2e0a
Autor:
Roberto Diaz-Beveridge, Luis Miguel De Sande-González, Antonio López Pousa, Jordi Rubió-Casadevall, Javier Martin-Broto, Pablo Luna, Juan Antonio Carrasco, Claudia M Valverde-Morales, Andres Poveda, Gloria Marquina, María Ángeles Vaz Salgado, Javier Martinez-Trufero, Antonio Gutierrez, Ana De Juan, Juana María Cano, Ibon Gurruchaga-Sotes, Isabel Sevilla, Josefina Cruz-Jurado, Jerónimo Martínez-García, Rosa Alvarez, David S. Moura
Publikováno v:
Cancers
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Cancers, Vol 13, Iss 792, p 792 (2021)
Scientia
Volume 13
Issue 4
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Cancers, Vol 13, Iss 792, p 792 (2021)
Scientia
Volume 13
Issue 4
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
The aim of this study was to identify an easily reliable prognostic score that selects the subset of advanced soft tissue sarcoma (ASTS) patients with a higher benefit with trabectedin in terms of time to progression and overall survival. A retrospec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7ae189020c1b9820dc01b3e6d0041c2
https://hdl.handle.net/10668/17307
https://hdl.handle.net/10668/17307
Autor:
Luis Miguel de Sande González, Axel Le Cesne, Bernd Kasper, Jean-Yves Blay, Javier Martin-Broto
Publikováno v:
Expert review of anticancer therapy. 20(11)
The efficacy and tolerability of trabectedin in patients with soft tissue sarcoma (STS) have been confirmed by various clinical studies involving lipo- and leiomyosarcomas as well as many other subtypes including translocation-related sarcomas. These
Autor:
L.F. Sánchez-Cousido, Pilar Diz Taín, Beatriz Nieto Mangudo, Ana Lopez-Gonzalez, Amaya Lanz Lozano, Luis Miguel de Sande, Mariana López-Flores, Angel Rodriguez Sanchez, Andrés García-Palomo, Carmen Castañón-López
Publikováno v:
Oral Oncology. 118:3
Autor:
Antonio Fernández-Serra, Raquel López-Reig, Raúl Márquez, Alejandro Gallego, Luís Miguel de Sande, Alfonso Yubero, Cristina Pérez-Segura, Avinash Ramchandani-Vaswani, María Pilar Barretina-Ginesta, Elsa Mendizábal, Carmen Esteban, Fernando Gálvez, Ana Beatriz Sánchez-Heras, Eva María Guerra-Alía, Lydia Gaba, María Quindós, Isabel Palacio, Jesús Alarcón, Ana Oaknin, Jessica Aliaga, Marta Ramírez-Calvo, Zaida García-Casado, Ignacio Romero, José Antonio López-Guerrero
Publikováno v:
Cancers, Vol 15, Iss 11, p 3030 (2023)
Genomic Instability (GI) is a transversal phenomenon shared by several tumor types that provide both prognostic and predictive information. In the context of high-grade serous ovarian cancer (HGSOC), response to DNA-damaging agents such as platinum-b
Externí odkaz:
https://doaj.org/article/2d35a4d7083e4e25ad4de6e679a72100